In 1910, Abraham Flexner published a report that would forever alter the course of American medicine. Commissioned by the Carnegie ...

The American healthcare system is quietly undergoing a financial transformation. As insurance premiums rise and administrative complexity deepens, more patients—and ...

Cardiologists and neurologists have long viewed atrial fibrillation (AFib) and dementia as two distinct clinical challenges. But a growing body ...

The news of 23andMe’s financial instability and potential bankruptcy isn’t just another tech-company flameout. It’s a watershed moment for the ...

As the U.S. retools its trade policies in an increasingly fractured global economy, tariffs—once seen as abstract economic levers—are becoming ...

Recent months have seen a steady exodus of senior leadership across the Department of Health and Human Services (DHHS), the ...

Healthcare has always existed at the intersection of science, politics, and public trust. But in today’s digital era, the loudest ...

Retatrutide isn’t FDA-approved. It’s still in clinical trials. But that hasn’t stopped people from trying to get their hands on ...

The COVID-19 pandemic served as a catalyst for the rapid adoption of telehealth services across the United States. As in-person ...

Physicians are no strangers to complexity. Navigating a medical diagnosis or interpreting clinical trial data can be as demanding as ...

Delays in Social Security payments can leave seniors and disabled individuals struggling to afford out-of-pocket healthcare costs. Learn how disruptions ...

Dr. Mehmet Oz, a prominent figure in conservative health policy, could leverage the Affordable Care Act (ACA) to weaken traditional ...